Nipro Corp, a leading Japanese company, operates in the healthcare industry, focusing on medical equipment and pharmaceutical products. With a diverse business model, Nipro Corp manufactures and sells various medical devices, including renal and infusion solutions, blood purification systems, and diabetes care products. Their pharmaceutical division is involved in the development and sales of generic drugs and therapeutic pharmaceuticals. Through strategic partnerships and acquisitions, Nipro Corp continues to expand its global presence and enhance its product offerings. As a renowned healthcare company, Nipro Corp remains committed to improving patient outcomes and contributing to the advancement of medical science worldwide.

Nipro Corp is primarily active in the healthcare industry.

The main competitors of Nipro Corp in the market include Medtronic, Becton, Dickinson and Company, Terumo Corporation, Abbott Laboratories, and Fresenius Medical Care.

Nipro Corp is a leading Japanese company in the healthcare sector. Founded in 1954, it has a rich history and strong background. Nipro Corp initially started as a manufacturer of medical devices, specializing in hypodermic needles and syringes. Over the years, the company expanded its product portfolio to include a wide range of medical equipment, pharmaceuticals, and renal products. Nipro Corp has established itself as a global player, serving healthcare professionals and patients worldwide. With a commitment to innovation and quality, Nipro Corp continues to contribute to the advancement of healthcare technologies and improve the lives of people globally.

Nipro Corp, a renowned company, has achieved several significant milestones throughout its history. The company has successfully established a global presence in the healthcare industry through its innovative solutions and dedication to excellence. Nipro Corp has made key advancements in the development of medical devices, pharmaceuticals, and renal products, positioning itself as a leader in these sectors. Furthermore, Nipro Corp has achieved notable accomplishments in expanding its market reach, enhancing its product portfolio, and fostering strategic collaborations. The company's commitment to continual growth and improvement has enabled it to leave a lasting impact on the healthcare field, making it a trusted and respected name in the industry.

Nipro Corp is primarily present in various countries and regions across the globe. The company has a strong international presence, with its main operations centered in Japan, its home country. Additionally, Nipro Corp actively conducts business in North America, Europe, Asia, and other parts of the world. With a diversified geographical reach, Nipro Corp aims to serve a wide range of customers and expand its market presence globally.

Nipro Corp is a leading company globally, known for its strong corporate philosophy and values. The company represents a commitment to innovation, quality, and sustainability in the healthcare industry. Nipro Corp aims to enhance patients' lives through advanced medical technologies, including dialysis products, medical devices, and pharmaceuticals. With a focus on patient-centric care, Nipro Corp strives to ensure the highest standards of safety, effectiveness, and affordability in their products. The company's core values emphasize integrity, teamwork, and social responsibility. Nipro Corp continuously endeavors to contribute to society and improve healthcare outcomes worldwide.

Analysts currently set an average price target of 1 470,84 JPY for the Nipro stock (median: 1 326,00 JPY), implying −5,3 % versus the latest price. The consensus is based on 9 analyst ratings.

Nipro Analyytikkojen kursstavoitteet 2026

9 analysts currently rate the Nipro stock: 5 recommend buying, 3 holding and 1 selling. For 2026, analysts expect Nipro to generate revenue of 675,21 Mrd. JPY and earnings per share of 84,03 JPY.

Nipro Analyytikkojen kursstavoitteet 2026

Converted at the current exchange rate, the Nipro share trades at 8,54 EUR (1 590,50 JPY).

The Nipro share (8086.T) is listed on 4 stock exchanges, including: Frankfurt (5FA.F), München (5FA.MU), Düsseldorf (5FA.DU).

The Nipro Corporation is a Japanese company that operates in various industries. Founded in 1954, the company has become a global player, offering a wide range of products and services. One of the company's main activities is the manufacturing of medical products. Thanks to advanced technology and extensive research and development, Nipro is able to offer its customers a variety of high-quality products that are used in both clinical and home environments. Nipro's medical products include infusion and dialysis devices, insulin pumps and injectors, blood glucose meters, catheters, stents, and other medical devices. Additionally, the company also offers a wide range of pharmaceutical products used to treat various diseases and ailments. In addition to healthcare, Nipro is also involved in other industries. For example, the company has a division for electronics products, including touchscreens, LED lighting technology, and energy storage systems. Here too, the company strives to develop innovative technologies and offer its customers high-quality products. Nipro is also active in the food industry, offering a wide range of natural foods and beverages. The company places special emphasis on sustainability and environmental friendliness, employing organic farming methods and resource-efficient production processes. Another important area for Nipro is environmental technology. The company develops and produces photovoltaic modules to harness renewable energies and water purification systems that enable sustainable water usage. In addition to product manufacturing, Nipro also provides consulting services to customers in various industries. The company supports its customers in the development of new products or services and helps optimize business processes. Overall, Nipro's business model is highly diversified, encompassing various industries and divisions. The company is committed to developing innovative technologies and offering its customers high-quality products and services. It also emphasizes sustainability and environmental friendliness, taking its responsibility towards society and the environment seriously.

odotettu liikevaihto Nipro on 675,21 Mrd. JPY. Tämä luku perustuu nykyisiin talousarvoihin ja heijastaa yhtiön liiketoimintasuoritusta.

odotettu voitto Nipro on 15,47 Mrd. JPY. Nettovoitto kuvastaa yhtiön kannattavuutta kaikkien kulujen vähentämisen jälkeen.

Nipro:n hinta-voitto-suhde (P/E) on tällä hetkellä 18,93. P/E-suhde vertaa nykyistä osakekurssia osakekohtaiseen tulokseen ja auttaa sijoittajia arvioimaan Nipro-osakkeen arvostusta.

Nipro:n hinta-myynti-suhde (P/S) on tällä hetkellä 0,43. P/S-suhde vertaa markkina-arvoa vuosittaisiin tuloihin ja toimii Nipro-osakkeen arvostuskennuslukuna.

Nipro:n Eulpool-laatuscore on 5/10.

Nipro:n ISIN on JP3673600007. ISIN (International Securities Identification Number) on maailmanlaajuisesti ainutlaatuinen arvopaperin tunnus.

Nipro:n WKN on 875746. WKN (Wertpapierkennnummer) on kuusinumeroinen saksalainen arvopaperin tunnus.

Nipro:n ticker on 8086.T. Tämä pörssinoteeraus käytetään Nipro-osakkeiden kauppaan pörssissä.

Viimeisten 12 kuukauden aikana Nipro maksoi osinkoa 23,00 JPY . Tämä vastaa osingontuottoa noin 1,45 %. Tulevien 12 kuukauden aikana Nipro odotetaan maksavan osinkoa 46,23 JPY.

Nipro:n nykyinen osinkotuotto on 1,45 %.

Nipro maksaa osinkoa, joka jaetaan kuukausina , , , .

Nipro maksoi osinkoa joka vuosi viimeisten 29 vuoden aikana.

Tulevien 12 kuukauden aikana odotetaan osinkoja, joiden määrä on 46,23 JPY. Tämä vastaa osingontuottoa 2,91 %.

Nipro kuuluu sektoriin 'Terveydenhuolto'.

Saadaksesi viimeisen osingon Nipro:sta päivältä määrässä 18 JPY, sinulla piti olla osake portfoliossasi ennen irtoamispäivää .

Viimeinen osinko maksettiin .

Vuonna 2025 Nipro jakoi 18,5 JPY osinkona.

Nipro:n osingot jaetaan valuutassa JPY.